Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)
To find a recommended dose of the combination of alpelisib and pembrolizumab that can be given to patients with metastatic breast cancer or melanoma.
Melanoma (Skin Cancer)Breast CancerBrain Metastasases
Estimated
~$10 – $6,250
M.D. Anderson Cancer CenterNCT06545682
Phase 1
A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases
This will be an open-label Phase 0/1 study that will enroll approximately 15 participants, 9 participants with recurrent WHO Grade 4 glioma (rGBM) and 6 partic…
Glioblastoma (GBM)Brain Metastasases
Estimated
~$10 – $7,500
Nader SanaiNCT07268053